Poseida Therapeutics
PSTX
8,80 €
Share price
0.00%
Change (1 day)
206.34%
Change (1 year)
Revenue for Poseida Therapeutics (PSTX)
Revenue in 2024 (TTM): €0.13 Billion
According to Poseida Therapeutics's latest financial reports the company's current revenue (TTM 
) is €0.13 Billion. In 2023 the company made a revenue of €58.53 Million a decrease over the revenue in the year 2022 that were of €0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Poseida Therapeutics from 2019 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | €0.13 B | 134.29% |
| 2023 | €58.53 M | -51.89% |
| 2022 | €0.12 B | 341.03% |
| 2021 | €27.58 M | |
| 2020 | N/A | |
| 2019 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |